ECDC Annual Epidemiological report

Syphilis infections on the rise in Europe

Solna, Sweden (May 18, 2016) – New data released in ECDC’s Annual Epidemiological report show that since 2010, the overall syphilis rates have been going up across Europe, particularly among men. In 2014, the reported syphilis numbers were six times higher in men than in women. Almost two-thirds (63%) of the syphilis cases reported with information on transmission category were recorded in men who have sex with men (MSM).

In 2014, 24 541 syphilis cases were reported in 29 EU/EEA Member States (no data from Austria and Liechtenstein), resulting in an overall rate of 5.1 per 100 000 population. The majority of infections were reported in people older than 25 years while young people between 15 and 24 accounted for only 13% of cases.

Between 2010 and 2014, many countries, particularly in western Europe, saw a sharp upsurge in the number of reported syphilis infections, with increases of over 50% in Belgium, France, Germany, Iceland, Ireland, Luxembourg, Malta, Norway, Portugal and the United Kingdom. While the data show a marked increase of syphilis cases among men across Europe, cases among women have decreased.

Largest increase among those aged 45 and over. Between 2005 and 2014, 208 134 cases of syphilis were reported in 30 countries. Over this decade, the proportion of cases among age groups below 35 years went down, while they went up among those aged 35 years or over. The largest increases were seen in those aged 45 years or over: their proportion rose from 18% to 30%.

The overall increasing trend of syphilis in many EU/EEA countries – driven by infections among MSM — is likely linked to changes in sexual behaviour in this group. More complete reporting and improved case detection through, for example, more testing among HIV-positive MSM, as recommended in current HIV management guidelines, have also contributed to this trend.

Promoting safe sexual behaviour and increasing testing rates among risk groups through targeted prevention campaigns is essential to prevent cases and reduce the risk of the complications of late stages of syphilis infection through earlier diagnosis. Approaches that use social media and dating apps for prevention campaigns may be considered in addition to traditional approaches.


More information


European Centre for Diseas e Prevention and Control (ECDC), 18.05.2016 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…